EGFR and non-small cell lung carcinoma: Although larger prospective studies are urgently needed to confirm these findings, based on published data, in a recent ESMO consensus, over 90% of experts did not recommend the use of consolidation ICIs therapy after curative-intent CRT in EGFR-positive NSCLC [155].